Is Clearside Biomedical Inc (CLSD) a Good Buy in the Biotechnology Industry?

Clearside Biomedical Inc (CLSD) is near the top in its industry group according to InvestorsObserver. CLSD gets an overall rating of 56. That means it scores higher than 56 percent of stocks. Clearside Biomedical Inc gets a 86 rank in the Biotechnology industry. Biotechnology is number 88 out of 148 industries.

CLSD has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on CLSD!

See Full CLSD Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Clearside Biomedical Inc Stock Today?

Clearside Biomedical Inc (CLSD) stock has gained 0.8% while the S&P 500 is lower by -0.36% as of 10:29 AM on Wednesday, Nov 24. CLSD has risen $0.03 from the previous closing price of $3.76 on volume of 42,205 shares. Over the past year the S&P 500 has gained 28.56% while CLSD has risen 128.31%. CLSD lost -$0.46 per share the over the last 12 months. Click Here to get the full Stock Report for Clearside Biomedical Inc stock.